Jennifer Crosby
Payments from drug & device makers
Across 208 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$600
- Novo Nordisk$364
- AstraZeneca$338
- Otsuka America Pharmaceutical, Inc.$337
- Lilly USA, LLC$289
- Vanda Pharmaceuticals Inc.$222
- plus $2K from 27 others
What the payments were for
- Food & beverage$3,801100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $600 |
| Novo Nordisk | 21 | $364 |
| AstraZeneca(2 entities) | 14 | $338 |
| Otsuka America Pharmaceutical, Inc. | 18 | $337 |
| Lilly USA, LLC | 17 | $289 |
| Vanda Pharmaceuticals Inc. | 11 | $222 |
| Amgen | 11 | $190 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $173 |
| Pfizer | 10 | $153 |
| Novartis | 5 | $139 |
| GSK | 7 | $124 |
| Exact Sciences | 4 | $74 |
| Bayer | 3 | $73 |
| Acadia Pharmaceuticals Inc | 3 | $72 |
| Nestle Healthcare Nutrition Inc. | 4 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| UCB, Inc. | 3 | $58 |
| Boehringer Ingelheim | 3 | $54 |
| Lundbeck LLC | 3 | $54 |
| Biohaven Pharmaceuticals, Inc. | 1 | $48 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| Harmony Biosciences LLC | 1 | $35 |
| Abbott | 2 | $31 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $30 |
| Corcept Therapeutics | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Actelion Pharmaceuticals US, Inc. | 1 | $24 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Viatris Specialty LLC | 1 | $19 |
| Astellas Pharma US Inc | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Neurelis, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$100
How this compares
$3,801 in reported general payments places this provider in the 90th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 56 | $83,346 |
| EliquisApixaban | 74 | $72,262 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 66 | $62,166 |
| OzempicSemaglutide | 30 | $42,148 |
| FarxigaDapagliflozin Propanediol | 34 | $34,114 |
| XareltoRivaroxaban | 29 | $32,433 |
| MounjaroTirzepatide | 19 | $28,822 |
| Nurtec OdtRimegepant Sulfate | 26 | $24,959 |
| JanuviaSitagliptin Phosphate | 24 | $23,356 |
| EntrestoSacubitril/Valsartan | 17 | $16,977 |
| JardianceEmpagliflozin | 16 | $15,326 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 45 | $7,839 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 18 | $5,463 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 156 | $5,369 |
| Novolog FlexpenInsulin Aspart | 15 | $5,280 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $289 | $112,16975 claims |
| PfizerEliquis, Nurtec Odt | $153 | $97,222100 claims |
| GSKTrelegy Ellipta | $124 | $62,16666 claims |
| Novo NordiskOzempic | $364 | $42,14830 claims |
| AstraZenecaFarxiga | $338 | $34,11434 claims |
| NovartisEntresto | $139 | $16,97717 claims |
| Boehringer IngelheimJardiance | $54 | $15,32616 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,657 family providers in Michigan.
Other family in Flint
- Rachael CompeauFlint$62K
- Julie WidzinskiFlint$16K
- Amy WulkeFlint$11K
- Laura SzakalFlint$10K
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.